Literature DB >> 31090066

APOBEC-mediated DNA alterations: A possible new mechanism of carcinogenesis in EBV-positive gastric cancer.

Irina Bobrovnitchaia1, Renan Valieris1, Rodrigo D Drummond1, Joao P Lima1,2, Helano C Freitas3,2, Thais F Bartelli3, Maria G de Amorim3, Diana N Nunes3, Emmanuel Dias-Neto3,4, Israel T da Silva1.   

Abstract

Mechanisms of viral oncogenesis are diverse and include the off-target activity of enzymes expressed by the infected cells, which evolved to target viral genomes for controlling their infection. Among these enzymes, the single-strand DNA editing capability of APOBECs represent a well-conserved viral infection response that can also cause untoward mutations in the host DNA. Here we show, after evaluating somatic single-nucleotide variations and transcriptome data in 240 gastric cancer samples, a positive correlation between APOBEC3s mRNA-expression and the APOBEC-mutation signature, both increased in EBV+ tumors. The correlation was reinforced by the observation of APOBEC mutations preferentially occurring in the genomic loci of the most active transcripts. This EBV infection and APOBEC3 mutation-signature axis were confirmed in a validation cohort of 112 gastric cancer patients. Our findings suggest that APOBEC3 upregulation in EBV+ cancer may boost the mutation load, providing further clues to the mechanisms of EBV-induced gastric carcinogenesis. After further validation, this EBV-APOBEC axis may prove to be a secondary driving force in the mutational evolution of EBV+ gastric tumors, whose consequences in terms of prognosis and treatment implications should be vetted.
© 2019 UICC.

Entities:  

Keywords:  APOBEC; EBV; gastric cancer

Mesh:

Substances:

Year:  2019        PMID: 31090066     DOI: 10.1002/ijc.32411

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Epstein-Barr virus and malaria upregulate AID and APOBEC3 enzymes, but only AID seems to play a major mutagenic role in Burkitt lymphoma.

Authors:  Andrea M Summerauer; Vera Jäggi; Rodney Ogwang; Sabrina Traxel; Lorenzo Colombo; Eivind Amundsen; Tatjana Eyer; Bibin Subramanian; Jan Fehr; Pierre-Yves Mantel; Richard Idro; Simone Bürgler
Journal:  Eur J Immunol       Date:  2022-05-12       Impact factor: 6.688

Review 2.  The Role of APOBECs in Viral Replication.

Authors:  Wendy Kaichun Xu; Hyewon Byun; Jaquelin P Dudley
Journal:  Microorganisms       Date:  2020-11-30

3.  Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer.

Authors:  Siyu Xia; Yun Gu; Haijian Zhang; Yuchao Fei; Yifan Cao; Hanji Fang; Jieti Wang; Chao Lin; Heng Zhang; He Li; Hongyong He; Jiejie Xu; Ruochen Li; Hao Liu; Weijuan Zhang
Journal:  Oncoimmunology       Date:  2021-09-15       Impact factor: 8.110

4.  Hypermethylation of RAD9A intron 2 in childhood cancer patients, leukemia and tumor cell lines suggest a role for oncogenic transformation.

Authors:  Danuta Galetzka; Julia Böck; Lukas Wagner; Marcus Dittrich; Olesja Sinizyn; Marco Ludwig; Heidi Rossmann; Claudia Spix; Markus Radsak; Peter Scholz-Kreisel; Johanna Mirsch; Matthias Linke; Walburgis Brenner; Manuela Marron; Alicia Poplawski; Thomas Haaf; Heinz Schmidberger; Dirk Prawitt
Journal:  EXCLI J       Date:  2022-01-07       Impact factor: 4.068

5.  Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis.

Authors:  O N Shilova; D L Tsyba; E S Shilov
Journal:  Mol Biol       Date:  2022-02-12       Impact factor: 1.374

Review 6.  Antiviral Responses in Cancer: Boosting Antitumor Immunity Through Activation of Interferon Pathway in the Tumor Microenvironment.

Authors:  Glauco Akelinghton Freire Vitiello; Wallax Augusto Silva Ferreira; Vladmir Cláudio Cordeiro de Lima; Tiago da Silva Medina
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

7.  EBV and further emerging directions towards increased precision in gastric cancer treatment.

Authors:  Luana B C Santos; Thais F Bartelli; Diana N Nunes; Emmanuel Dias-Neto
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

8.  EBV-LMP1 induces APOBEC3s and mitochondrial DNA hypermutation in nasopharyngeal cancer.

Authors:  Kousho Wakae; Satoru Kondo; Hai Thanh Pham; Naohiro Wakisaka; Lusheng Que; Yingfang Li; Xin Zheng; Kento Fukano; Kouichi Kitamura; Koichi Watashi; Hideki Aizaki; Takayoshi Ueno; Makiko Moriyama-Kita; Kazuya Ishikawa; Yosuke Nakanishi; Kazuhira Endo; Masamichi Muramatsu; Tomokazu Yoshizaki
Journal:  Cancer Med       Date:  2020-08-20       Impact factor: 4.452

Review 9.  Roles of APOBEC3 in hepatitis B virus (HBV) infection and hepatocarcinogenesis.

Authors:  Yuan Zhang; Xiaorong Chen; Yajuan Cao; Zongguo Yang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.